黑洞:在AML中使用CAR T细胞疗法
Erden Atilla1,2, Karim Benabdellah2
1Fred Hutchinson Cancer Research Center, Clinical Research Division, 1100 Fairview Ave N, Seattle, WA 98109, USA.
Cancers
|June 22, 2023
概括
采用细胞疗法在治疗复发性/耐药性急性髓性白血病 (AML) 方面面临挑战,原因是患者异质性. 新的策略,如先进的CAR T细胞疗法和向新抗原,对于改善患者反应至关重要.
科学领域:
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- 与B细胞恶性瘤相比,采用细胞疗法在复发/耐药急性髓性白血病 (AML) 中表现出有限的成功.
- 目前针对AML的仿真抗原受体 (CAR) T细胞试验的响应率很低 (约. 30%) 和瘤外的毒性.
- 在AML中,高的患者内和患者间异质性带来了重大治疗挑战.
研究的目的:
- 审查AML中采用细胞疗法的挑战.
- 讨论最近的单细胞测序数据,以了解AML异质性.
- 总结改善AML治疗结果的新策略.
主要方法:
- 对AML采用细胞疗法的现有文献的审查.
- 对最近的单细胞测序数据进行分析,以描述AML异质性.
- 新兴治疗方法和策略的综合.
主要成果:
- 由于细胞异质性,CAR T细胞和其他AML的采用疗法存在重大挑战.
- 单细胞测序揭示了AML中DNA,表观遗传,RNA和蛋白质水平的复杂变化.
- 新的策略为提高疗效和降低毒性提供了潜力.
结论:
- 为了在AML中有效采用细胞疗法,需要改变范式.
- 了解AML的细胞生态系统是开发更好的治疗方法的关键.
- 下一代CAR T,TCR-T,CAR NK和全原方法具有前景.
更多相关视频
09:34Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
Published on: February 17, 2022
3.4K
12:55Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
Published on: February 16, 2015
21.5K
相关概念视频
Stem Cell Therapy for Tissue Regeneration
4.1K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.1K
Tumor Immunotherapy
575
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
575
